HIMSHIMS
US • —
$34.67
P/E
62.51
PEG
—
FCF Yield
—
Rev Growth YoY
+32.8% YoY
Gross Margin
72.9%
Health Score
4/10
D/E Ratio
1.80
Confidence
LOW
Business Snapshot
Hims & Hers Health operates a direct-to-consumer telehealth platform offering prescription and over-the-counter wellness products across dermatology, sexual health, mental health, and weight loss. The company competes as a challenger in the digital healthcare space, differentiating itself through a vertically integrated model that combines online consultations with proprietary and partnered fulfillment. While TTM revenue is not available from the provided data, the company has reported a 32.8% year-over-year revenue increase, indicating meaningful growth at a modest absolute scale. A defining characteristic is its consumer-facing brand and subscription-based revenue model, which creates a recurring customer base but also ties performance to customer acquisition costs and retention.
Financial Health
Gross margin stands at 72.9%, placing it in a healthy range typical of asset-light, service-oriented businesses, though no prior-year comparison is available to assess margin trajectory. Net margin is slightly negative at -0.6%, indicating the company is near breakeven on a trailing twelve-month basis but not yet consistently profitable...
Risk Assessment
- VALUATION — P/E of 62.51x is significantly elevated versus the sector average of 22x, leaving limited room for multiple compression without a price decline.
- EARNINGS QUALITY — The company beat analyst estimates in only 2 of the last 4 quarters, indicating that guidance credibility is mixed and earnings surprises have been split evenly.
- DEBT / LIQUIDITY — Debt/equity of 1.8x is elevated for a growth-stage company, suggesting the balance sheet carries a meaningful leverage burden that could limit financial flexibility.
- FCF / CASH BURN — Free cash flow data is not present in the payload, preventing an assessment of cash generation; however, the negative net margin of -0.6% implies the business is not yet self-sustaining.
- TECHNICALS — RSI, MACD, and moving average data are unavailable for this period; momentum cannot be independently confirmed.
- VALUATION DIVERGENCE — Both the FMP DCF and Python DCF values are unavailable due to negative or missing free cash flow, leaving the stock without an intrinsic valuation anchor....
Gross margin stands at 72.9%, placing it in a healthy range typical of asset-light, service-oriented businesses, though no prior-year comparison is available to assess margin trajectory. Net margin is slightly negative at -0.6%, indicating the company is near breakeven on a trailing twelve-month basis but not yet consistently profitable. The balance sheet carries a debt-to-equity ratio of 1.8x, which is elevated for an early-stage growth company, though the current ratio of 1.9x suggests sufficient short-term liquidity to cover obligations. Free cash flow data is not present in the payload, making it impossible to assess whether the business is self-funding or dependent on external capital. Without positive net margins or free cash flow visibility, the company has limited capacity to self-fund expansion and may face dilution risk if capital markets tighten.
- VALUATION — P/E of 62.51x is significantly elevated versus the sector average of 22x, leaving limited room for multiple compression without a price decline. - EARNINGS QUALITY — The company beat analyst estimates in only 2 of the last 4 quarters, indicating that guidance credibility is mixed and earnings surprises have been split evenly. - DEBT / LIQUIDITY — Debt/equity of 1.8x is elevated for a growth-stage company, suggesting the balance sheet carries a meaningful leverage burden that could limit financial flexibility. - FCF / CASH BURN — Free cash flow data is not present in the payload, preventing an assessment of cash generation; however, the negative net margin of -0.6% implies the business is not yet self-sustaining. - TECHNICALS — RSI, MACD, and moving average data are unavailable for this period; momentum cannot be independently confirmed. - VALUATION DIVERGENCE — Both the FMP DCF and Python DCF values are unavailable due to negative or missing free cash flow, leaving the stock without an intrinsic valuation anchor.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives